Categories: News

RaySearch to exhibit the latest software innovations for particle therapy at PTCOG 2022

 STOCKHOLM, June 27, 2022  /PRNewswire/ — RaySearch Laboratories AB (publ) will exhibit at PTCOG 60, to be held in Miami, Florida, USA, during June 27-July 1. The latest news in treatment planning system RayStation®*, oncology information system RayCare®* and oncology analytics system RayIntelligence® will be on show. Book a demo at raysearchlabs.com.

RaySearch software on show 

RaySearch is a proud market leader in particle therapy planning and workflow software. The latest clinical features of the advanced treatment planning system RayStation include include GPU-based Monte Carlo dose computation in under five seconds, Linear Energy Transfer including RBE dose calculations, and fully automated deep learning planning including robustness. 

Attendees can also catch a glimpse of upcoming features such as proton ARC planning, dose computation on CBCT, LET optimization, and FLASH planning.

RayCare, the oncology information system from RaySearch offers improved configurability of workflows, enabling the creation of clinical notes, documents and forms which are integrated directly into the patient chart. Improvements to patient chart, extension of summary workspace, and increased support for radiotherapy processes are all included in RayCare.

RayIntelligence is a cloud-based oncology analytics system that simplifies data integrations and turns data into insights. It supports patient and treatment population analysis through web based dashboards as well as via interfaces for advanced analytics.

RaySearch scientific contributions at PTCOG

Wednesday, June 29th, 14:20 – 15:00, Room 3

Reducing high LET component of dose to the brainstem in proton treatment planning for brain tumors by optimization

Authors: Vestergaard, Anne; Høyer, Morten, Kallehauge, Jesper; Nørrevang, Ole; Smulders, Bob; Lassen-Ramshad Yasmin; Muhic, Aida; Dahlrot, Rikke; Traneus, Erik; Korreman, Stine.

Presenter: Anne Vestergaard, Aarhus University

Robustness in proton arc treatments for head and neck cancer patients: impact of gantry angle spacing and number of revolutions

Authors: Marthin, Otte; Wase, Viktor; Glimelius, Lars; Bokrantz, Rasmus; Andersson, Björn; Fredriksson, Albin; de Jong, Bas; Korevaar, Erik W.; Both, Stefan; Engwall, Erik. 

Presenter: Lars Glimelius, Senior Product Manager Light Ions

Poster PTC60-0058:  Re-Assessment of Radiation Fields Applied to Clinical Proton Beam Therapy and Related Key Technical Requirements

Poster PTC60-0048: LETd measurements of double-scattered proton fields with patient-specific range-compensator and aperture using silicon on insulator microdosimeter

Poster PTC60-0417: Conformal FLASH Proton therapy planning with RayStation

 

CONTACT:

For more information, please contact:

Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)

Telephone: +46 (0) 8 510 530 00

johan.lof@raysearchlabs.com

Björn Hårdemark, interim CFO, RaySearch Laboratories AB (publ) 

Telephone: +46 (0) 709 564 217

bjorn.hardemark@raysearchlabs.com

 

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/raysearch-laboratories/r/raysearch-to-exhibit-the-latest-software-innovations-for-particle-therapy-at-ptcog-2022,c3591919

The following files are available for download:

View original content:https://www.prnewswire.com/news-releases/raysearch-to-exhibit-the-latest-software-innovations-for-particle-therapy-at-ptcog-2022-301575650.html

SOURCE RaySearch Laboratories

Staff

Recent Posts

Unique Treatment for BPH, Chronic Prostatitis, Back Pain and Kidney Stones Was Unveiled at Arab Health 2024 by Ariana Adjani

* Efficacy, safety, and cost-effectiveness of Thermobalancing therapy and Dr Allen's Devices were showcased at…

19 hours ago

Financière de Tubize – Annual report 2023

FINANCIERE DE TUBIZE SA/NV Allée de la Recherche 60, 1070 Brussels Contact: investorrelations@financiere-tubize.be Annual Report…

2 days ago

ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call

PLEASANTON, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP…

2 days ago

Ibogaine By David Dardashti Leverages Albert Einstein’s Corelation Between Photon Particles and Quantum Electrodynamics

Ibogaine By David Dardashti Revolutionizes Solar Energy Efficiency Through Radiation Generators Einstein A young and…

2 days ago

Psyence Biomedical Ltd. Receives Nasdaq Notifications Regarding Market Value of Listed Securities and Market Value of Publicly Held Shares

NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (the “Company”) (Nasdaq: PBM)…

2 days ago

NurExone’s Strategic Update: Submission of OTCQB Listing Application to Initiate US financial presence

TORONTO and HAIFA, Israel, March 15, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX)…

2 days ago